GEN Exclusives

More »

GEN Poll

More »
Feb 26, 2014

Greg Lucier: Life after Life Tech

In a single decade, Greg Lucier, 49, transformed the relatively small firm Invitrogen into the international behemoth Life Technologies. Now that Thermo Fisher Scientific has completed its acquisition of Life Tech, Lucier says he may try “to serve in some appointed or possibly even elected capacity.” (For more on Greg Lucier, click here.) Would you vote for Lucier?

Would you vote for former Life Technologies CEO Greg Lucier if he ran for public office?

Yes
 
  58.1%
No
 
  41.9%

More Polls » View Results »

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?